| Cub Pharmacy #1608/604 | |
| 585 Northtown Dr Ne, Blaine, Minnesota 55434 | |
| (763) 780-7350 |
| Name | Cub Pharmacy #1608/604 |
|---|---|
| Organization Name | Supervalu Pharmacies Inc |
| Location | 585 Northtown Dr Ne, Blaine, Minnesota 55434 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (763) 780-7350 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Value in Health, the official journal of ISPOR, announced today the publication of a scoping review of the US Food and Drug Administration Pilot Clinical Outcome Assessment Compendium.
The rate of drug-resistant staph hospital-acquired infections has dropped as the U.S. has stepped up prevention efforts to fight the deadly condition, The Associated Press reports. "The decline was seen in a federal study of methicillin-resistant staph, or MRSA. The bug often causes only a boil or skin infection. But researchers in the study focused on invasive cases that can become deadly, invading the bloodstream, flesh, lungs and bones. Researchers found that in nine metro areas, cases of MRSA (MUR'-suh) fell about 16 percent between 2005 and 2008.
Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.
Many low- and middle-income countries do not have a defined medical specialty in surgical oncology and lack an educational infrastructure to respond to the local burden of cancer, but a Memorial Sloan Kettering Cancer Center fellowship is succeeding in addressing this problem by training foreign medical graduates (FMG) in surgical oncology.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.
› Verified 2 days ago
| NPI Number | 1225143365 |
| Organization Name | SUPERVALU PHARMACIES INC |
| Doing Business As | CUB PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 585 Northtown Dr Ne, Blaine, MN 55434 |
| Phone Number | 763-780-7350 |
News Archive
Value in Health, the official journal of ISPOR, announced today the publication of a scoping review of the US Food and Drug Administration Pilot Clinical Outcome Assessment Compendium.
The rate of drug-resistant staph hospital-acquired infections has dropped as the U.S. has stepped up prevention efforts to fight the deadly condition, The Associated Press reports. "The decline was seen in a federal study of methicillin-resistant staph, or MRSA. The bug often causes only a boil or skin infection. But researchers in the study focused on invasive cases that can become deadly, invading the bloodstream, flesh, lungs and bones. Researchers found that in nine metro areas, cases of MRSA (MUR'-suh) fell about 16 percent between 2005 and 2008.
Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.
Many low- and middle-income countries do not have a defined medical specialty in surgical oncology and lack an educational infrastructure to respond to the local burden of cancer, but a Memorial Sloan Kettering Cancer Center fellowship is succeeding in addressing this problem by training foreign medical graduates (FMG) in surgical oncology.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.
› Verified 2 days ago
News Archive
Value in Health, the official journal of ISPOR, announced today the publication of a scoping review of the US Food and Drug Administration Pilot Clinical Outcome Assessment Compendium.
The rate of drug-resistant staph hospital-acquired infections has dropped as the U.S. has stepped up prevention efforts to fight the deadly condition, The Associated Press reports. "The decline was seen in a federal study of methicillin-resistant staph, or MRSA. The bug often causes only a boil or skin infection. But researchers in the study focused on invasive cases that can become deadly, invading the bloodstream, flesh, lungs and bones. Researchers found that in nine metro areas, cases of MRSA (MUR'-suh) fell about 16 percent between 2005 and 2008.
Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.
Many low- and middle-income countries do not have a defined medical specialty in surgical oncology and lack an educational infrastructure to respond to the local burden of cancer, but a Memorial Sloan Kettering Cancer Center fellowship is succeeding in addressing this problem by training foreign medical graduates (FMG) in surgical oncology.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.
› Verified 2 days ago
Cvs Pharmacy #07152 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2357 108th Ln Ne, Blaine, Minnesota 55449 Phone: (763) 780-0776 | |
Cvs Pharmacy #16953 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 109th Ave Ne, Blaine, Minnesota 55449 Phone: (763) 354-1001 | |
Walgreens #5413 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 600 County Road 10 Ne, Blaine, Minnesota 55434 Phone: (763) 786-9081 | |
Walgreens #7781 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4202 Pheasant Ridge Dr Ne, Blaine, Minnesota 55449 Phone: (651) 255-1498 | |
Walgreens #7218 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12480 Aberdeen St Ne, Blaine, Minnesota 55449 Phone: (763) 862-6596 |